-
1
-
-
0030775362
-
Prevalence of dry eye among the elderly
-
Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124(6):723-728.
-
(1997)
Am J Ophthalmol
, vol.124
, Issue.6
, pp. 723-728
-
-
Schein, O.D.1
Munoz, B.2
Tielsch, J.M.3
Bandeen-Roche, K.4
West, S.5
-
2
-
-
0037645975
-
Prevalence of dry eye among an elderly Chinese population in Taiwan: The Shihpai Eye Study
-
Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110(6):1096-1101.
-
(2003)
Ophthalmology
, vol.110
, Issue.6
, pp. 1096-1101
-
-
Lin, P.Y.1
Tsai, S.Y.2
Cheng, C.Y.3
Liu, J.H.4
Chou, P.5
Hsu, W.M.6
-
3
-
-
0035164394
-
Dry eye disease: The scale of the problem
-
Brewitt H, Sistani F. Dry eye disease: the scale of the problem. Surv Ophthalmol. 2001;45(suppl 2):S199-S202.
-
(2001)
Surv Ophthalmol
, vol.45
, Issue.SUPPL. 2
-
-
Brewitt, H.1
Sistani, F.2
-
4
-
-
0037816581
-
Utility assessment among patients with dry eye disease
-
Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110(7):1412-1419.
-
(2003)
Ophthalmology
, vol.110
, Issue.7
, pp. 1412-1419
-
-
Schiffman, R.M.1
Walt, J.G.2
Jacobsen, G.3
Doyle, J.J.4
Lebovics, G.5
Sumner, W.6
-
5
-
-
0027510403
-
The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors
-
Fryback DG, Dasbach EJ, Klein R, et al.The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13(2):89-102.
-
(1993)
Med Decis Making
, vol.13
, Issue.2
, pp. 89-102
-
-
Fryback, D.G.1
Dasbach, E.J.2
Klein, R.3
-
7
-
-
0018155086
-
The utility of different health states as perceived by the general public
-
Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis. 1978;31(11):697-704.
-
(1978)
J Chronic Dis
, vol.31
, Issue.11
, pp. 697-704
-
-
Sackett, D.L.1
Torrance, G.W.2
-
8
-
-
0036850062
-
A meta-analysis of utility estimates for HIV/AIDS
-
Tengs TO, Lin TH. A meta-analysis of utility estimates for HIV/AIDS. Med Decis Making. 2002;22(6):475-481.
-
(2002)
Med Decis Making
, vol.22
, Issue.6
, pp. 475-481
-
-
Tengs, T.O.1
Lin, T.H.2
-
9
-
-
33847082853
-
Impact of dry eye syndrome on vision-related quality of life
-
Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143(3):409-415.
-
(2007)
Am J Ophthalmol
, vol.143
, Issue.3
, pp. 409-415
-
-
Miljanović, B.1
Dana, R.2
Sullivan, D.A.3
Schaumberg, D.A.4
-
10
-
-
34147142303
-
Clinical performance of a mid-viscosity artificial tear for dry eye treatment
-
Simmons PA, Vehige JG. Clinical performance of a mid-viscosity artificial tear for dry eye treatment. Cornea. 2007;26(3):294-302.
-
(2007)
Cornea
, vol.26
, Issue.3
, pp. 294-302
-
-
Simmons, P.A.1
Vehige, J.G.2
-
11
-
-
22444448251
-
Silicone versus collagen plugs for treating dry eye: Results of a prospective randomized trial including lacrimal scintigraphy
-
Altan-Yaycioglu R, Gencoglu EA, Akova YA, Dursun D, Cengiz F, Akman A. Silicone versus collagen plugs for treating dry eye: results of a prospective randomized trial including lacrimal scintigraphy. Am J Ophthalmol. 2005;140(1):88-93.
-
(2005)
Am J Ophthalmol
, vol.140
, Issue.1
, pp. 88-93
-
-
Altan-Yaycioglu, R.1
Gencoglu, E.A.2
Akova, Y.A.3
Dursun, D.4
Cengiz, F.5
Akman, A.6
-
12
-
-
33748925223
-
A permanent and reversible procedure to block tear drainage for the treatment of dry eye
-
DeMartelaere SL, Blaydon SM, Tovilla-Canales JL, Shore JW. A permanent and reversible procedure to block tear drainage for the treatment of dry eye. Ophthal Plast Reconstr Surg. 2006;22(5):352-355.
-
(2006)
Ophthal Plast Reconstr Surg
, vol.22
, Issue.5
, pp. 352-355
-
-
DeMartelaere, S.L.1
Blaydon, S.M.2
Tovilla-Canales, J.L.3
Shore, J.W.4
-
13
-
-
0018233657
-
Punctal occlusion in keratoconjunctivitis sicca
-
Dohlman CH. Punctal occlusion in keratoconjunctivitis sicca. Ophthalmology. 1978:85(12):1277-1281.
-
(1978)
Ophthalmology
, vol.85
, Issue.12
, pp. 1277-1281
-
-
Dohlman, C.H.1
-
14
-
-
0022980246
-
The autoimmune nature of aqueous tear deficiency
-
Pflugfelder SC, Jones D, Ji Z, et al. The autoimmune nature of aqueous tear deficiency. Ophthalmology. 1986;93(12):1513-1517.
-
(1986)
Ophthalmology
, vol.93
, Issue.12
, pp. 1513-1517
-
-
Pflugfelder, S.C.1
Jones, D.2
Ji, Z.3
-
15
-
-
33947364762
-
Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome
-
Hong S, Kim T, Chung SH, Kim EK, Seo KY. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome. J Ocul Pharmacol Ther. 2007;23(1):78-82.
-
(2007)
J Ocul Pharmacol Ther
, vol.23
, Issue.1
, pp. 78-82
-
-
Hong, S.1
Kim, T.2
Chung, S.H.3
Kim, E.K.4
Seo, K.Y.5
-
16
-
-
34250192888
-
Systemic immunomodulatory therapy in severe dry eye secondary to inflammation
-
Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm. 2007;15(2):99-104.
-
(2007)
Ocul Immunol Inflamm
, vol.15
, Issue.2
, pp. 99-104
-
-
Cordero-Coma, M.1
Anzaar, F.2
Sobrin, L.3
Foster, C.S.4
-
17
-
-
0027954030
-
Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome
-
Günd̈z K, Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome. Acta Ophthalmol (Copenh). 1994;72(4):438-442.
-
(1994)
Acta Ophthalmol (Copenh)
, vol.72
, Issue.4
, pp. 438-442
-
-
Günd̈z, K.1
Ozdemir, O.2
-
18
-
-
0034105080
-
CsA Phase 3 Study Group. Two randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease
-
Sall K, Stevenson OD, Mundorf TK, Reis BL; CsA Phase 3 Study Group. Two randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107(4):631-639.
-
(2000)
Ophthalmology
, vol.107
, Issue.4
, pp. 631-639
-
-
Sall, K.1
Stevenson, O.D.2
Mundorf, T.K.3
Reis, B.L.4
-
19
-
-
0033801265
-
Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose-ranging, randomized trial: the Cyclosporin A Phase 2 Study Group
-
Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial: the Cyclosporin A Phase 2 Study Group. Ophthalmology.2000;107(5):967-974.
-
(2000)
Ophthalmology
, vol.107
, Issue.5
, pp. 967-974
-
-
Stevenson, D.1
Tauber, J.2
Reis, B.L.3
-
20
-
-
0033822741
-
The diagnosis and management of dry eye: A twenty-five-year review
-
Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea. 2000;19(5):644-649.
-
(2000)
Cornea
, vol.19
, Issue.5
, pp. 644-649
-
-
Pflugfelder, S.C.1
Solomon, A.2
Stern, M.E.3
-
21
-
-
25844450960
-
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years
-
Barber LD, Pflugfelder SC, Tauber J, Foulks GN. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology. 2005;112(10):1790-1794.
-
(2005)
Ophthalmology
, vol.112
, Issue.10
, pp. 1790-1794
-
-
Barber, L.D.1
Pflugfelder, S.C.2
Tauber, J.3
Foulks, G.N.4
-
22
-
-
60849107840
-
-
Restatis (cyclosporine ophthalmic emulsion) 0.05%. Allergan Inc Web site. http://www.restasisprofessional.com. Accessed April 8, 2008.
-
Restatis (cyclosporine ophthalmic emulsion) 0.05%. Allergan Inc Web site. http://www.restasisprofessional.com. Accessed April 8, 2008.
-
-
-
-
24
-
-
0037353837
-
Health care economic analyses and value-based medicine
-
Brown MM, Brown GC, Sharma S, Landy J. Health care economic analyses and value-based medicine. Surv Ophthalmol. 2003;48(2):204-223.
-
(2003)
Surv Ophthalmol
, vol.48
, Issue.2
, pp. 204-223
-
-
Brown, M.M.1
Brown, G.C.2
Sharma, S.3
Landy, J.4
-
25
-
-
33750796886
-
Value-based medicine: A paradigm for quality pharmaceutical care
-
Brown MM, Brown GC, Sharma S. Value-based medicine: a paradigm for quality pharmaceutical care. Drug Benefit Trends. 2006;18:285-289.
-
(2006)
Drug Benefit Trends
, vol.18
, pp. 285-289
-
-
Brown, M.M.1
Brown, G.C.2
Sharma, S.3
-
26
-
-
0036241252
-
Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients
-
Sharma S, Brown GC, Brown MM, Hollands H, Robins R, Shah GK. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol. 2002;86(5):493-496.
-
(2002)
Br J Ophthalmol
, vol.86
, Issue.5
, pp. 493-496
-
-
Sharma, S.1
Brown, G.C.2
Brown, M.M.3
Hollands, H.4
Robins, R.5
Shah, G.K.6
-
27
-
-
0036690670
-
Patient, community and clinician perceptions of the quality of life associated with diabetes mellitus
-
Landy J, Stein JD, Brown GC, Brown MM, Sharma S. Patient, community and clinician perceptions of the quality of life associated with diabetes mellitus. Med Sci Monit. 2002;8(8):CR543-CR548.
-
(2002)
Med Sci Monit
, vol.8
, Issue.8
-
-
Landy, J.1
Stein, J.D.2
Brown, G.C.3
Brown, M.M.4
Sharma, S.5
-
28
-
-
0033675436
-
Difference between ophthalmologist and patient perceptions of quality-of-life associated with age-related macular degeneration
-
Brown GC, Brown MM, Sharma S. Difference between ophthalmologist and patient perceptions of quality-of-life associated with age-related macular degeneration. Can J Ophthalmol. 2000;35(3):127-133.
-
(2000)
Can J Ophthalmol
, vol.35
, Issue.3
, pp. 127-133
-
-
Brown, G.C.1
Brown, M.M.2
Sharma, S.3
-
29
-
-
0036081826
-
The quality of life of patients with hypertension
-
Stein JD, Brown GC, Brown MM, Sharma S, Hollands H, Stein HD. The quality of life of patients with hypertension. J Clin Hypertens (Greenwich). 2002;4(3):181-188.
-
(2002)
J Clin Hypertens (Greenwich)
, vol.4
, Issue.3
, pp. 181-188
-
-
Stein, J.D.1
Brown, G.C.2
Brown, M.M.3
Sharma, S.4
Hollands, H.5
Stein, H.D.6
-
30
-
-
0034594429
-
Quality-of-life associated with diabetes mellitus in an adult population
-
Brown GC, Brown MM, Sharma S, Brown H, Gozum M, Denton P. Quality-of-life associated with diabetes mellitus in an adult population. J Diabetes Complications. 2000;14(1):18-24.
-
(2000)
J Diabetes Complications
, vol.14
, Issue.1
, pp. 18-24
-
-
Brown, G.C.1
Brown, M.M.2
Sharma, S.3
Brown, H.4
Gozum, M.5
Denton, P.6
-
31
-
-
0036145093
-
Quality-of-life and systemic comorbidities in patients with ophthalmic disease
-
Brown MM, Brown GC, Sharma S, Hollands H, Landy J. Quality-of-life and systemic comorbidities in patients with ophthalmic disease. Br J Ophthalmol. 2002:86(1):8-11.
-
(2002)
Br J Ophthalmol
, vol.86
, Issue.1
, pp. 8-11
-
-
Brown, M.M.1
Brown, G.C.2
Sharma, S.3
Hollands, H.4
Landy, J.5
-
32
-
-
0035754933
-
The reproducibility of ophthalmic utility values
-
Brown GC, Brown MM, Sharma S, Beauchamp G, Hollands H. The reproducibility of ophthalmic utility values. Trans Am Ophthalmol Soc. 2001;99:199-203.
-
(2001)
Trans Am Ophthalmol Soc
, vol.99
, pp. 199-203
-
-
Brown, G.C.1
Brown, M.M.2
Sharma, S.3
Beauchamp, G.4
Hollands, H.5
-
33
-
-
0012164128
-
-
Center for Drug Evaluation and Research application 21-023, Accessed April 4, 2008
-
Center for Drug Evaluation and Research application 21-023. Center for Drug Evaluation and Research Web site. http://www.fda.gov/cder/foi/nda/2003/21- 023-Restasis-Medr.PDF. Accessed April 4, 2008.
-
Center for Drug Evaluation and Research Web site
-
-
-
34
-
-
0035081975
-
Utility values associated with blindness in an adult population
-
Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol. 2001;85(3):327-331.
-
(2001)
Br J Ophthalmol
, vol.85
, Issue.3
, pp. 327-331
-
-
Brown, M.M.1
Brown, G.C.2
Sharma, S.3
Kistler, J.4
Brown, H.5
-
35
-
-
0033370961
-
Vision and quality of life
-
Brown GC. Vision and quality of life. Trans Am Ophthalmol Soc. 1999;97:473-512.
-
(1999)
Trans Am Ophthalmol Soc
, vol.97
, pp. 473-512
-
-
Brown, G.C.1
-
36
-
-
0033986170
-
Utility values and age-related macular degeneration
-
Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol. 2000;118(1):47-51.
-
(2000)
Arch Ophthalmol
, vol.118
, Issue.1
, pp. 47-51
-
-
Brown, G.C.1
Sharma, S.2
Brown, M.M.3
Kistler, J.4
-
37
-
-
0036305925
-
Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration
-
Brown MM, Brown GC, Sharma S, Landy J, Bakal J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol. 2002;120(4):481-484.
-
(2002)
Arch Ophthalmol
, vol.120
, Issue.4
, pp. 481-484
-
-
Brown, M.M.1
Brown, G.C.2
Sharma, S.3
Landy, J.4
Bakal, J.5
-
38
-
-
0032876618
-
Utility values and diabetic retinopathy
-
Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol. 1999;128(3):324-330.
-
(1999)
Am J Ophthalmol
, vol.128
, Issue.3
, pp. 324-330
-
-
Brown, M.M.1
Brown, G.C.2
Sharma, S.3
Shah, G.4
-
39
-
-
44349110000
-
-
Brown GC, Brown MM, Brown H, Peet JS. A value-based medicine analysis of ranibizumab (MARINA Study) for the treatment of subfoveal neovascular macular degeneration [published online ahead of print November 5, 2007]. Ophthalmology. 2008;115(6):1039-1045.e5.
-
Brown GC, Brown MM, Brown H, Peet JS. A value-based medicine analysis of ranibizumab (MARINA Study) for the treatment of subfoveal neovascular macular degeneration [published online ahead of print November 5, 2007]. Ophthalmology. 2008;115(6):1039-1045.e5.
-
-
-
-
40
-
-
0343963066
-
Reliability and validity of the Ocular Surface Disease Index
-
Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118(5):615-621.
-
(2000)
Arch Ophthalmol
, vol.118
, Issue.5
, pp. 615-621
-
-
Schiffman, R.M.1
Christianson, M.D.2
Jacobsen, G.3
Hirsch, J.D.4
Reis, B.L.5
-
41
-
-
36148967079
-
-
Centers for Medicare and Medicaid Services physician fee schedule overview, Accessed September 20, 2007
-
Centers for Medicare and Medicaid Services physician fee schedule overview. Centers for Medicare and Medicaid Services Web site. http://www.cms.hhs.gov/apps/ama/license.asp?file=physicianfeesched/downloads/ pe-townhall-hcpcs-level.zip. Accessed September 20, 2007.
-
Centers for Medicare and Medicaid Services Web site
-
-
-
42
-
-
60849131336
-
-
Current procedural terminology, fourth edition. American Medical Association Web site. https://catalog.ama-assn.org/Catalog/cpt/cpt-search.jsp? check-Xwho=done. Accessed February 15, 2008.
-
Current procedural terminology, fourth edition. American Medical Association Web site. https://catalog.ama-assn.org/Catalog/cpt/cpt-search.jsp? check-Xwho=done. Accessed February 15, 2008.
-
-
-
-
46
-
-
0029919387
-
Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses
-
Siegel JE, Weinstein MC, Russell LB, Gold MR; Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996;276(16):1339-1341.
-
(1996)
JAMA
, vol.276
, Issue.16
, pp. 1339-1341
-
-
Siegel, J.E.1
Weinstein, M.C.2
Russell, L.B.3
Gold, M.R.4
-
47
-
-
60849104582
-
-
The Guidelines Manual chapter 8: incorporating health economics in guidelines and assessing resource impact. National Institute for Health and Clinical Excellence Web site. http://www.nice.org.uk/niceMedia/pdf/ GuidelinesManualChapter8.pdf. Accessed April 3, 2008.
-
The Guidelines Manual chapter 8: incorporating health economics in guidelines and assessing resource impact. National Institute for Health and Clinical Excellence Web site. http://www.nice.org.uk/niceMedia/pdf/ GuidelinesManualChapter8.pdf. Accessed April 3, 2008.
-
-
-
-
48
-
-
60849135218
-
-
The world health report 2002: reducing risks, promoting health life. World Health Organization Web site. www.who.int/whr/2002/en/. Accessed May 17, 2008.
-
The world health report 2002: reducing risks, promoting health life. World Health Organization Web site. www.who.int/whr/2002/en/. Accessed May 17, 2008.
-
-
-
-
49
-
-
34247326604
-
Value-based medicine and interventions for macular degeneration
-
Brown MM, Brown GC, Brown H. Value-based medicine and interventions for macular degeneration. Curr Opin Ophthalmol. 2007;18(3):194-200.
-
(2007)
Curr Opin Ophthalmol
, vol.18
, Issue.3
, pp. 194-200
-
-
Brown, M.M.1
Brown, G.C.2
Brown, H.3
-
50
-
-
34247248392
-
A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration
-
Brown GC, Brown MM, Brown HC, Kindermann S, Sharma S. A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration Ophthalmology. 2007;114(6):1170-1178.
-
(2007)
Ophthalmology
, vol.114
, Issue.6
, pp. 1170-1178
-
-
Brown, G.C.1
Brown, M.M.2
Brown, H.C.3
Kindermann, S.4
Sharma, S.5
-
51
-
-
0037583136
-
A cost-utility analysis of cataract surgery in the second eye
-
Busbee BG, Brown MM, Brown GC, Sharma S. A cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003;110(12):2310- 2317.
-
(2003)
Ophthalmology
, vol.110
, Issue.12
, pp. 2310-2317
-
-
Busbee, B.G.1
Brown, M.M.2
Brown, G.C.3
Sharma, S.4
-
52
-
-
0036184981
-
Incremental cost-effectiveness of initial cataract surgery
-
Busbee BG, Brown MM, Brown GC, Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology. 2002;109(3):606-612.
-
(2002)
Ophthalmology
, vol.109
, Issue.3
, pp. 606-612
-
-
Busbee, B.G.1
Brown, M.M.2
Brown, G.C.3
Sharma, S.4
-
53
-
-
0030932860
-
The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms
-
Mushlin AI, Mooney C, Holloway RC, Detsky AS, Mattson DH, Phelps CE. The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms. Int J Technol Assess Health Care. 1997;13(1):21-34.
-
(1997)
Int J Technol Assess Health Care
, vol.13
, Issue.1
, pp. 21-34
-
-
Mushlin, A.I.1
Mooney, C.2
Holloway, R.C.3
Detsky, A.S.4
Mattson, D.H.5
Phelps, C.E.6
-
54
-
-
0030963729
-
Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV
-
Pinkerton SD, Holtgrave DR, Pinkerton HJ. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med. 1997;157(17):1972-1980.
-
(1997)
Arch Intern Med
, vol.157
, Issue.17
, pp. 1972-1980
-
-
Pinkerton, S.D.1
Holtgrave, D.R.2
Pinkerton, H.J.3
-
55
-
-
0033890241
-
Antiviral therapies for herpes zoster infections: Are they economically justifiable?
-
Smith KJ, Roberts MS. Antiviral therapies for herpes zoster infections: are they economically justifiable? Pharmacoeconomics. 2000;18(2):95-104.
-
(2000)
Pharmacoeconomics
, vol.18
, Issue.2
, pp. 95-104
-
-
Smith, K.J.1
Roberts, M.S.2
-
56
-
-
0037292467
-
A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-1b in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis
-
Touchette DR, Durgin TL, Wanke LA, Goodkin DE. A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-1b in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis. Clin Ther. 2003;25(2):611-634.
-
(2003)
Clin Ther
, vol.25
, Issue.2
, pp. 611-634
-
-
Touchette, D.R.1
Durgin, T.L.2
Wanke, L.A.3
Goodkin, D.E.4
-
57
-
-
0036129303
-
Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine
-
Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol. 2002;120(3):330-337.
-
(2002)
Arch Ophthalmol
, vol.120
, Issue.3
, pp. 330-337
-
-
Kunert, K.S.1
Tisdale, A.S.2
Gipson, I.K.3
|